Downregulation of p57 kip2 promotes cell invasion via LIMK/cofilin pathway in human nasopharyngeal carcinoma cells

Journal of Cellular Biochemistry

Volumn 112, Issue 11, 2011, Pages 3459-3468

  Chow, Shu Er ^a   Wang, Jong Shyan ^a   Lin, Ming Rung ^a   Lee, Chien Lin ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

CELL MIGRATION; COFILIN; LIMK; NPC; p57 kip2

Indexed keywords

COFILIN; LIM KINASE 1; MITOMYCIN C; PROTEIN P57; SMALL INTERFERING RNA; COFILIN 1; CYCLIN DEPENDENT KINASE INHIBITOR 1C; LIM KINASE;

ARTICLE; CANCER INVASION; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; DOWN REGULATION; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; GENETICS; METABOLISM; NASOPHARYNX TUMOR; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; COFILIN 1; CYCLIN-DEPENDENT KINASE INHIBITOR P57; DOWN-REGULATION; HUMANS; LIM KINASES; MICROSCOPY, FLUORESCENCE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 80055019362     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23277     Document Type: Article

References (36)

1. Barbieri CE, Tang LJ, Brown KA, Pietenpol JA,. 2006. Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis. Cancer Res 66: 7589-7597. (Pubitemid 44289215)
2. Bernard O,. 2007. Lim kinases, regulators of actin dynamics. Int J Biochem Cell Biol 39: 1071-1076. (Pubitemid 46819128)
3. Besson A, Assoian RK, Roberts JM,. 2004. Regulation of the cytoskeleton: An oncogenic function for cdk inhibitors ? Nat Rev Cancer 4: 948-955. (Pubitemid 39626218)
4. Besson A, Dowdy SF, Roberts JM,. 2008. CDK inhibitors: Cell cycle regulators and beyond. Dev Cell 14: 159-169. (Pubitemid 351189186)
5. Chiang CT, Chu WK, Chow SE, Chen JK,. 2009. Overexpression of delta Np63 in a human nasopharyngeal carcinoma cell line downregulates CKIs and enhances cell proliferation. J Cell Physiol 219: 117-122.
6. Chou J, Lin YC, Kim J, You L, Xu Z, He B, Jablons DM,. 2008. Nasopharyngeal carcinoma-Review of the molecular mechanisms of tumorigenesis. Head Neck 30: 946-963. (Pubitemid 352008957)
7. Chow SE, Wang JS, Chuang SF, Chang YL, Chu WK, Chen WS, Chen YW,. 2010. Resveratrol-induced p53-independent apoptosis of human nasopharyngeal carcinoma cells is correlated with the downregulation of [Delta]Np63. Cancer Gene Ther 17: 872-882.
8. Chow SE, Chang YL, Chuang SF, Wang JS,. 2011. Wogonin induced apoptosis in human nasopharyngeal carcinoma cells by targeting GSK-3β and δNp63. Cancer Chemother Pharmacol [Epub ahead of reprint]. DOI: 10.1007/s00280-010-1552-1.
9. DesMarais V, Ghosh M, Eddy R, Condeelis J,. 2005. Cofilin takes the lead. J Cell Sci 118: 19-26. (Pubitemid 40277101)
10. Fan GK, Chen J, Ping F, Geng Y,. 2006a. Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues. Oral Oncol 42: 147-153. (Pubitemid 43106879)
11. Fan GK, Xu F, Yang B, Fujieda S,. 2006b. p57kip2 expression is related to carcinogenesis and tumor progression in laryngeal tissues. Acta Otolaryngol 126: 301-305. (Pubitemid 43259236)
12. Ghosh M, Song X, Mouneimne G, Sidani M, Lawrence DS, Condeelis JS,. 2004. Cofilin promotes actin polymerization and defines the direction of cell motility. Science 304: 743-746. (Pubitemid 38560882)
13. Guo C, Pan Z-G, Li D-J, Yun J-P, Zheng M-Z, Hu Z-Y, Cheng L-Z, Zeng Y-X,. 2006. The expression of p63 is associated with the differential stage in nasopharyngeal carcinoma and EBV infection. J Transl Med 4: 23.
14. Horikawa T, Yang J, Kondo S, Yoshizaki T, Joab I, Furukawa M, Pagano JS,. 2007. Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma. Cancer Res 67: 1970-1978. (Pubitemid 46424213)
15. Ichikawa T, Suenaga Y, Koda T, Ozaki T, Nakagawara A,. 2008. [Delta]Np63/BMP-7-dependent expression of matrilin-2 is involved in keratinocyte migration in response to wounding. Biochem Biophysl Res Commun 369: 994-1000.
16. Ito Y, Takeda T, Sakon M, Tsujimoto M, Monden M, Matsuura N,. 2001. Expression of p57/Kip2 protein in hepatocellular carcinoma. Oncology 61: 221-225. (Pubitemid 34701537)
17. Jin RJ, Lho Y, Wang Y, Ao M, Revelo MP, Hayward SW, Wills ML, Logan SK, Zhang P, Matusik RJ,. 2008. Down-regulation of p57Kip2 induces prostate cancer in the mouse. Cancer Res 68: 3601-3608.
18. Kommagani R, Leonard MK, Lewis S, Romano RA, Sinha S, Kadakia MP,. 2009. Regulation of VDR by {Delta}Np63{alpha} is associated with inhibition of cell invasion. J Cell Sci 122: 2828-2835.
19. Lee S, Helfman DM,. 2004. Cytoplasmic p21Cip1 is involved in Ras-induced inhibition of the ROCK/LIMK/Cofilin pathway. J Biol Chem 279 (3): 1885-1891. (Pubitemid 38084458)
20. Lin CT, Wong CI, Chan WY, Tzung KW, Ho JK, Hsu MM, Chuang SM,. 1990. Establishment and characterization of two nasopharyngeal carcinoma cell lines. Lab Invest 62: 713-724. (Pubitemid 20213689)
21. Lo KW, To KF, Huang DP,. 2004. Focus on nasopharyngeal carcinoma. Cancer Cell 5: 423-428. (Pubitemid 38612865)
22. Muller M, Schleithoff ES, Stremmel W, Melino G, Krammer PH, Schilling T,. 2006. One, two, three-p53, p63, p73 and chemosensitivity. Drug Resist Updat 9: 288-306.
23. Nakai S, Masaki T, Shiratori Y, Ohgi T, Morishita A, Kurokohchi K, Watanabe S, Kuriyama S,. 2002. Expression of p57KIP2 in hepatocellular carcinoma: Relationship between tumor differentiation and patient survival. Int J Oncol 20: 769-775.
24. Nan K, Guo H, Ruan ZP, Jing Z, Liu SX,. 2005. Expression of p57kip2 and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma. World J Gastroenterol 11: 237-1240.
25. Pateras IS, Apostolopoulou K, Niforou K, Kotsinas A, Gorgoulis VG,. 2009. p57KIP2: "Kip"ing the Cell under Control. Mol Cancer Res 7: 1902-1919.
26. Ridley AJ,. 2001. Rho GTPases and cell migration. J Cell Sci 114: 2713-2722. (Pubitemid 32785451)
27. Sakai K, Peraud A, Mainprize T, Nakayama J, Tsugu A, Hongo K, Kobayashi S, Rutka J,. 2004. Inducible expression of p57KIP2 inhibits glioma cell motility and invasion. J Neuro-Oncol 68: 217-223. (Pubitemid 38878255)
28. Sui L, Dong Y, Ohno M, Atanabe Y, Sugimoto K, Tokuda M,. 2002. Expression of p57kip2 and its clinical relevance in epithelial ovarian tumors. Anticancer Res 22: 3191-3196. (Pubitemid 36070092)
29. Sun Y, Hegamyer G, Cheng Y, Hildesheim A, Chen J, Chen I, Cao Y, Yao K, Colburn N,. 1992. An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma. Proc Natl Acad Sci USA 89: 6516-6520.
30. Vlachos P, Joseph B,. 2009. The Cdk inhibitor p57Kip2 controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics. Oncogene 28: 4175-4188.
31. Vlachos P, Nyman U, Hajji N, Joseph B,. 2007. The cell cycle inhibitor p57Kip2 promotes cell death via the mitochondrial apoptotic pathway. Cell Death Differ 14: 1497-1507. (Pubitemid 47086736)
32. Yamazaki D, Kurisu S, Takenawa T,. 2005. Regulation of cancer cell motility through actin reorganization. Cancer Sci 96: 379-386. (Pubitemid 41179738)
33. Yang N, Higuchi O, Ohashi K, Ohashi K, Nagata K, Wada A, Kangawa K, Nishida E, Mizuno K,. 1998. Cofilin phosphorylation by LIM-kinase 1 and its role in Rac-mediated actin reorganization. Nature 393: 809-812. (Pubitemid 28299495)
34. Yang X, Karuturi RK, Sun F, Aau M, Yu K, Shao R, Miller LD, Tan PB, Yu Q,. 2009. CDKN1C (p57KIP2) is adirect target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells. PLoS One 4: e5011.
35. Yip YL, Tsao SW,. 2008. Regulation of p63 expression in primary and immortalized nasopharyngeal epithelial cells. Int J Oncol 33: 713-724.
36. Yokoo T, Toyoshima H, Miura M, Wang Y, Iida KT, Suzuki H, Sone H, Shimano H, Gotoda T, Nishimori S, Tanaka K, Yamada N,. 2003. p57Kip2 regulates actin dynamics by binding and translocating LIM-kinase 1 to the nucleus. J Biol Chem 278: 52919-52923. (Pubitemid 38035893)